B
CVS Health Corporation
CVS
NYSE
$93.05 -$0.97-1.03% Volume4,547,692 05/19/2022 3:18PM Eastern Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
B
Buy 5/4/2022Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/4/2022 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.9761 to $1.74, EBIT increased 12.15% from $3.11B to $3.49B, and total revenue increased 0.77% from $76.24B to $76.83B.
B
Buy 4/28/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 4/28/2022 due to a noticeable decline in the total return index and volatility index.
B
Buy 4/18/2022Downgrade
CVS Health Corporation (CVS) was downgraded to B+ from A- on 4/18/2022 due to a noticeable decline in the total return index, growth index and solvency index.
A
Buy 3/29/2022Upgraded
CVS Health Corporation (CVS) was upgraded to A- from B+ on 3/29/2022 due to a large increase in the total return index and volatility index.
B
Buy 3/15/2022Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 3/15/2022 due to a major increase in the growth index, volatility index and total return index. Total revenue increased 3.66% from $73.55B to $76.24B, and EBIT increased 3.34% from $3.27B to $3.38B.
B
Buy 12/13/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 12/13/2021 due to an increase in the volatility index.
B
Buy 11/4/2021Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 11/4/2021 due to a large decline in the growth index, efficiency index and dividend index. Earnings per share declined from $2.1 to $1.2, net income declined 42.58% from $2.78B to $1.6B, and EBIT declined 14.37% from $4.08B to $3.49B.
B
Buy 10/22/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 10/22/2021 due to an increase in the total return index, growth index and efficiency index. Operating cash flow increased 102.18% from $2.89B to $5.85B, net income increased 25.19% from $2.22B to $2.78B, and earnings per share increased from $1.68 to $2.1.
B
Buy 4/26/2021Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 4/26/2021 due to a decline in the valuation index and dividend index.
B
Buy 4/6/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 4/6/2021 due to an increase in the total return index and volatility index.
B
Buy 3/9/2021Upgraded
CVS Health Corporation (CVS) was upgraded to B- from C+ on 3/9/2021 due to an increase in the total return index, valuation index and volatility index.
C
Hold 2/22/2021Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 2/22/2021 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 90.34% from $1.87B to $3.57B, debt to equity declined from 0.98 to 0.94, and total revenue increased 3.67% from $66.85B to $69.31B.
C
Hold 3/12/2020Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 3/12/2020 due to a decline in the total return index and volatility index.
C
Hold 1/21/2020Upgraded
CVS Health Corporation (CVS) was upgraded to C+ from C on 1/21/2020 due to a noticeable increase in the volatility index and total return index.
C
Hold 9/30/2019Upgraded
CVS Health Corporation (CVS) was upgraded to C from C- on 9/30/2019 due to an increase in the volatility index and total return index.
C
Hold 8/13/2019Upgraded
CVS Health Corporation (CVS) was upgraded to C- from D+ on 8/13/2019 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 174.02% from $1.95B to $5.34B, earnings per share increased from $1.09 to $1.4873, and net income increased 36.24% from $1.42B to $1.94B.
D
Sell 3/4/2019Downgrade
CVS Health Corporation (CVS) was downgraded to D+ from C- on 3/4/2019 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 130.14% from $1.39B to -$419M, and earnings per share declined from $1.36 to -$0.3756.
C
Hold 2/28/2019Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 2/28/2019 due to a decline in the volatility index and total return index.
C
Hold 9/12/2018Upgraded
CVS Health Corporation (CVS) was upgraded to C from C- on 9/12/2018 due to an increase in the solvency index, volatility index and total return index.
C
Hold 11/21/2017Downgrade
CVS Health Corporation (CVS) was downgraded to C- from C on 11/21/2017 due to a large decline in the total return index, growth index and volatility index.
C
Hold 11/21/2016Downgrade
CVS Health Corporation (CVS) was downgraded to C from C+ on 11/21/2016 due to a decline in the volatility index and total return index.
C
Hold 11/3/2016Downgrade
CVS Health Corporation (CVS) was downgraded to C+ from B- on 11/3/2016 due to a decline in the volatility index and total return index.
B
Buy 10/17/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B on 10/17/2016 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.61 to 0.54, and debt to equity increased from 0.76 to 0.82.
B
Buy 6/3/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B from B+ on 6/3/2016 due to a decline in the total return index.
B
Buy 5/19/2016Upgraded
CVS Health Corporation (CVS) was upgraded to B+ from B on 5/19/2016 due to a large increase in the volatility index, total return index and efficiency index.
B
Buy 3/28/2016Upgraded
CVS Health Corporation (CVS) was upgraded to B from B- on 3/28/2016 due to an increase in the total return index and volatility index.
B
Buy 3/11/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B- from B+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
B
Buy 2/18/2016Downgrade
CVS Health Corporation (CVS) was downgraded to B+ from A- on 2/18/2016 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.74 to 0.62, and debt to equity increased from 0.73 to 0.74.
A
Buy 9/29/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 9/29/2015 due to a decline in the volatility index and total return index.
A
Buy 9/14/2015Upgraded
CVS Health Corporation (CVS) was upgraded to A from A- on 9/14/2015 due to an increase in the valuation index and total return index.
A
Buy 8/28/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 8/28/2015 due to a decline in the total return index.
A
Buy 8/13/2015Upgraded
CVS Health Corporation (CVS) was upgraded to A from A- on 8/13/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 7.08% from $2.13B to $2.28B, earnings per share increased from $1.0701 to $1.12, and net income increased 4.18% from $1.22B to $1.27B.
A
Buy 5/26/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A- from A on 5/26/2015 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 42.04% from $3.42B to $1.98B, EBIT declined 8.14% from $2.32B to $2.13B, and the quick ratio declined from 0.64 to 0.6.
A
Buy 4/30/2015Downgrade
CVS Health Corporation (CVS) was downgraded to A from A+ on 4/30/2015 due to a decline in the total return index, valuation index and dividend index.
A
Buy 11/19/2014Upgraded
CVS Health Corporation (CVS) was upgraded to A+ from A on 11/19/2014 due to a major increase in the total return index, growth index and efficiency index. Operating cash flow increased 83.39% from $897M to $1.65B, EBIT increased 1.72% from $2.21B to $2.25B, and total revenue increased 1.21% from $34.6B to $35.02B.
A
Buy 5/5/2014Upgraded
CVS Caremark Corporation (CVS) was upgraded to A from A- on 5/5/2014 due to an increase in the solvency index, growth index and valuation index. Operating cash flow increased 41.22% from $1.54B to $2.17B.
A
Buy 4/23/2014Downgrade
CVS Caremark Corporation (CVS) was downgraded to A- from A on 4/23/2014 due to a decline in the total return index, valuation index and volatility index.
Weiss Ratings